Market Tracker

11/27 1:05pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

53.70
Data as of Nov 26
 -0.29 / -0.54%
Today’s Change
41.99
Today|||52-Week Range
80.42
+2.09%
Year-to-Date

Today’s Trading

Previous close53.99
Today’s open53.83
Day’s range53.40 - 54.48
Volume220,137
Average volume (3 months)387,342
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+69.44%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio162.7
Price/Sales21.82
Price/Book22.15

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.77-1.92%
MACKMerrimack Pharmaceut...+0.23+2.41%
NLNKNewLink Genetics Cor...+3.19+9.04%
TSROTESARO Inc+0.84+2.48%
Data as of 4:00pm ET, 11/26/2014

Financials

Next reporting dateFebruary 10, 2015
EPS forecast (this quarter)$0.62
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts